0.9599
Milestone Scientific Inc. stock is traded at $0.9599, with a volume of 35,810.
It is up +4.05% in the last 24 hours and down -11.94% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.9226
Open:
$0.97
24h Volume:
35,810
Relative Volume:
0.54
Market Cap:
$75.33M
Revenue:
$8.88M
Net Income/Loss:
$-4.62M
P/E Ratio:
-14.28
EPS:
-0.0672
Net Cash Flow:
$-2.66M
1W Performance:
-3.53%
1M Performance:
-11.94%
6M Performance:
+2.63%
1Y Performance:
+31.87%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MLSS
Milestone Scientific Inc.
|
0.9599 | 78.47M | 8.88M | -4.62M | -2.66M | -0.0672 |
![]()
ISRG
Intuitive Surgical Inc
|
553.88 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
168.98 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
85.39 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
244.15 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
BAX
Baxter International Inc
|
29.32 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-16-20 | Initiated | Northland Capital | Market Perform |
Nov-16-18 | Reiterated | Maxim Group | Buy |
Dec-23-16 | Reiterated | Maxim Group | Buy |
Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
Major Shareholder Sheds Milestone Scientific Stock in Noteworthy Transaction - TipRanks
Inter Scientific Achieves UK GLP Monitoring Authority Status to Support Regulatory Studies for Medicines, Devices and Novel Products - FinancialContent
Milestone Scientific Reports Increased Quarterly Loss - TipRanks
Benchmark maintains $1.25 target on Milestone Scientific stock - Investing.com
Benchmark maintains $1.25 target on Milestone Scientific stock By Investing.com - Investing.com India
Milestone Scientific adds new board member to drive growth By Investing.com - Investing.com South Africa
Milestone Scientific adds new board member to drive growth - Investing.com Australia
Milestone Scientific Appoints New Independent Director - TipRanks
Milestone Scientific Appoints Highly Accomplished MedTech Execut - GuruFocus
Milestone Scientific Inc. Appoints Shanth Thiyagalingam to Board of Directors to Enhance Strategic Growth and Innovation - Nasdaq
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors - GlobeNewswire
Milestone Scientific Lands PainTEQ CEO to Drive Medicare Reimbursement Strategy - Stock Titan
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 - The Manila Times
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025 | MLSS Stock News - GuruFocus
Milestone Scientific Medical Sales Surge 586% After Medicare Coverage Win for CompuFlo System - Stock Titan
Rigetti Shares Down 15% Post Q1 Earnings: Time to Buy, Hold or Sell? - TradingView
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data - The Manila Times
Nexalin Technology Reconstitutes Scientific Advisory Board - GlobeNewswire
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data - The Globe and Mail
StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS) - Defense World
Space exploration | History, Definition, & Facts - Britannica
Renaissance Technologies LLC Buys 53,198 Shares of Milestone Scientific Inc. (NYSE:MLSS) - Defense World
Envestnet Asset Management Inc. Takes $203,000 Position in Universal Technical Institute, Inc. (NYSE:UTI) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com - Defense World
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants - ACCESS Newswire
Milestone Scientific Inc. to Host Earnings Call - ACCESS Newswire
Protara Therapeutics, Inc. (NASDAQ:TARA) Shares Sold by LPL Financial LLC - Defense World
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - Defense World
Benchmark maintains Buy on Milestone Scientific, $1.25 target By Investing.com - Investing.com South Africa
Benchmark maintains Buy on Milestone Scientific, $1.25 target - Investing.com Australia
Charles & Colvard, Ltd. Announces Delisting from Nasdaq - Quantisnow
Milestone Scientific earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025 - The Manila Times
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025 | MLSS Stock News - GuruFocus
Milestone Scientific Reports Year-End 2024 Financial Results And Reports Strong Outlook For 2025 - marketscreener.com
Milestone Scientific Inc. Expands CompuFlo® Epidural System Adoption Following Medicare Price Approvals in Multiple States - Nasdaq
Milestone Scientific Cuts Losses 32% as Medicare Coverage Expands: 2024 Earnings Deep Dive - Stock Titan
Milestone Medical, Inc. Announces Management Changes - marketscreener.com
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter - GlobeNewswire
Milestone Scientific Announces Validation and Implementation of Quick Start to the CompuFlo Epidural System - ACCESS Newswire
‘A revolutionary milestone’: Colossal Biosciences announces de-extinction of the dire wolves - KXAN Austin
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves - Business Wire
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval - TradingView
Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen - Yahoo Finance
IAC completes spin-off of Angi Inc. - Yahoo Finance
Milestone Scientific expands CompuFlo Epidural System footprint with InfiniSurg - Yahoo Finance
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey - The Manila Times
CEA Industries Inc. Provides Update on Acquisition of Leading Canadian Vape Retailer and Manufacturer, Fat Panda Ltd. - The Manila Times
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):